2017 American Transplant Congress » Concurrent Session: Antibody Mediated Rejection in Kidney Transplant Recipients: Pathophsiology and Epidimiology

Date: Monday, May 1, 2017

Time: 4:30pm-6:00pm

Location: E354a

Session Type: Concurrent Session

Meeting: 2017 American Transplant Congress

4:30pm-4:42pm: Lower Incidence of DSA-Induced Chronic Antibody-Mediated Rejection in Abo-Incompatible Renal Transplantation.

M. Okada,¹ Y. Watarai,¹ K. Iwasaki,² K. Futamura,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²

4:42pm-4:54pm: Meta-Analysis of Clinical Significance of Complement Activating Anti-HLA DSA in Kidney Transplantation.

A. Bouquegneau,^1,2 C. Ulloa,¹ O. Aubert,¹ C. Loheac,¹ D. Viglietti,¹ J. Empana,¹ P. Jabre,¹ X. Jouven,¹ C. Lefaucheur,¹ A. Loupy.¹

4:54pm-5:06pm: Glomerular CD45 Immunostaining in Post Perfusion Graft Biopsies Predicting Rejection.

A. Yuvaraj, A. Prasad, K. Gopalakrishnan, N. Krishnan.

5:06pm-5:18pm: The Molecular Phenotypes of Rejection in Kidney Transplant Biopsies.

P. Halloran, J. Reeve, INTERCOMEX Study Group.

5:18pm-5:30pm: The Natural History of Kidney Rejection: How Do Molecular Disease States Change Over Time in Patients with Repeat Indication Biopsies?

J. Reeve, P. Halloran.

5:30pm-5:42pm: Endocapillary NK Cells Are Increased in Indication Renal Transplant Biopsies with Antibody and T Cell Mediated Rejection.

A. Shammout, J. Barnes, E. Farkash.

5:42pm-5:54pm: Immunodominant Donor Specific Antibody Reduction with Proteasome Inhibitor Based Treatment: Clinical Variability and Implications for Long Term Graft Survival.

A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ A. Shields,² B. Abu Jawdeh,¹ B. Hardy,¹ M. Anand,¹ M. Cuffy,¹ M. Cardi,¹ R. Alloway,¹ E. Woodle.¹

« View all sessions from the 2017 American Transplant Congress